ATE357451T1 - METHOD FOR PRODUCING TRANS- OR CIS-DIAMMONIUM DICHLORODIHYDROXOPLATIN (IV) SALTS AND DERIVATIVES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVE INGREDIENTS - Google Patents
METHOD FOR PRODUCING TRANS- OR CIS-DIAMMONIUM DICHLORODIHYDROXOPLATIN (IV) SALTS AND DERIVATIVES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVE INGREDIENTSInfo
- Publication number
- ATE357451T1 ATE357451T1 AT04789998T AT04789998T ATE357451T1 AT E357451 T1 ATE357451 T1 AT E357451T1 AT 04789998 T AT04789998 T AT 04789998T AT 04789998 T AT04789998 T AT 04789998T AT E357451 T1 ATE357451 T1 AT E357451T1
- Authority
- AT
- Austria
- Prior art keywords
- cis
- diammonium
- derivatives
- salts
- trans
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052697 platinum Inorganic materials 0.000 abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000008065 acid anhydrides Chemical class 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Production of trans- or cis-diammonium dichloro-dihydroxo-platinum (IV) (i.e. trans- or cis-oxoplatin) (A) or their derivatives involves reacting trans- or cis-diammonium dichloro-platinum (II) (B) with hydrogen peroxide solution of concentration more than 30% at less than 30[deg]C, dissolving the product with mineral acid and precipitating with alkaline solution. Some salts and other derivatives of (A), i.e. (A,), are new compounds. An independent claim is included for new salts and other derivatives of (A), having formula (H 3N) 2Pt(OX 1)(OX 2)Cl 2 (A'). X 1, X 2calcium, magnesium, sodium, potassium, lithium, alkyl or aryl. (N.B. Compounds (A'; X 1, X 2 = alkyl or aryl) are described in the disclosure as esters (rather than ethers), and are prepared from the corresponding bases and acid anhydrides). ACTIVITY : Cytostatic. Cis-diammonium dichloro-dihydroxo-platinum (IV) disodium salt ((H 3N) 2Pt(ONa)(ONa)Cl 2) (A'') had IC 5 0 2.5 mu g/ml against SW480 (colon cancer) cells, compared with 8.2 mu g/ml for the corresponding free base. MECHANISM OF ACTION : None given in the source material.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03090344A EP1524273B1 (en) | 2003-10-13 | 2003-10-13 | Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(IV) salts and derivatives and their use for the preparation of pharmaceutical active agents |
| US51209703P | 2003-10-20 | 2003-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357451T1 true ATE357451T1 (en) | 2007-04-15 |
Family
ID=34354539
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03090344T ATE346076T1 (en) | 2003-10-13 | 2003-10-13 | METHOD FOR PRODUCING TRANS- OR CIS-DIAMMONIUM DICHLORODIHYDROXOPLATIN (IV) SALTS AND DERIVATIVES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVE INGREDIENTS |
| AT04789998T ATE357451T1 (en) | 2003-10-13 | 2004-10-13 | METHOD FOR PRODUCING TRANS- OR CIS-DIAMMONIUM DICHLORODIHYDROXOPLATIN (IV) SALTS AND DERIVATIVES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVE INGREDIENTS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03090344T ATE346076T1 (en) | 2003-10-13 | 2003-10-13 | METHOD FOR PRODUCING TRANS- OR CIS-DIAMMONIUM DICHLORODIHYDROXOPLATIN (IV) SALTS AND DERIVATIVES AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVE INGREDIENTS |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7687651B2 (en) |
| EP (2) | EP1524273B1 (en) |
| JP (1) | JP4887153B2 (en) |
| CN (1) | CN100526324C (en) |
| AT (2) | ATE346076T1 (en) |
| AU (1) | AU2004283125B2 (en) |
| BR (1) | BRPI0415295A (en) |
| CA (1) | CA2565096C (en) |
| DE (3) | DE50305768D1 (en) |
| DK (1) | DK1678189T3 (en) |
| ES (1) | ES2284061T3 (en) |
| HK (1) | HK1097848A1 (en) |
| MX (1) | MXPA06003843A (en) |
| PL (1) | PL1678189T3 (en) |
| RU (1) | RU2345086C2 (en) |
| UA (1) | UA85066C2 (en) |
| WO (1) | WO2005040045A2 (en) |
| ZA (1) | ZA200603018B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE347367T1 (en) * | 2003-10-13 | 2006-12-15 | Zoser B Salama | PHARMACEUTICAL COMPOSITION COMPRISING OXOPLATIN AND SALTS THEREOF |
| CZ296459B6 (en) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Peroral pharmaceutical composition for targeted transport of platinum complex into colorectal region, process for its preparation, and the composition used as a medicament |
| WO2009156706A1 (en) * | 2008-06-27 | 2009-12-30 | University Of Strathclyde | Pulmonary drug delivery with vesicles comprising non-ionic surfactants |
| US9556214B2 (en) | 2012-12-19 | 2017-01-31 | Placon Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| CN103043635B (en) * | 2012-12-25 | 2015-04-22 | 浙江大学 | Drug-resistant cisplatin mineralization liquid and preparation method and application thereof |
| EP4311830A1 (en) * | 2022-07-29 | 2024-01-31 | King Faisal Specialist Hospital & Research Centre | Cisplatin analogue with potent anti-cancer effects and synthesis thereof |
| WO2024023197A1 (en) * | 2022-07-29 | 2024-02-01 | King Faisal Specialist Hospital & Research Centre | Cisplatin analogue with potent anti-cancer and cancer stem cell-targeting effects and synthesis thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1585103A (en) * | 1976-04-06 | 1981-02-25 | Rustenburg Platinum Mines Ltd | Pharmaceutical compositions containing platinum compounds |
| IL63658A0 (en) * | 1980-09-03 | 1981-11-30 | Johnson Matthey Plc | Co-ordination compound of platinum and its preparation |
| SU1021116A1 (en) | 1981-11-20 | 1996-11-20 | МГУ им. М.В.Ломоносова | Method of preparing cis-diammine-dichloro-dihydroxoplatinum(iv) |
| SU1137698A1 (en) * | 1983-10-17 | 1996-09-27 | МГУ им. М.В.Ломоносова | Process for preparing cis- diaminodichlorodihydroxoplatinum(iv) |
| ATE113054T1 (en) * | 1988-02-02 | 1994-11-15 | Johnson Matthey Inc | PT(IV) COMPLEXES. |
| US5196555A (en) * | 1989-10-17 | 1993-03-23 | Bristol-Myers Squibb Company | Water and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activity |
| RU2086261C1 (en) * | 1994-07-08 | 1997-08-10 | Химический факультет Московского государственного университета им.М.В.Ломоносова | Antitumor agent |
| JPH10251285A (en) * | 1997-03-14 | 1998-09-22 | Ss Pharmaceut Co Ltd | Platinum (iv) complex and medicine containing the same |
| ATE347367T1 (en) | 2003-10-13 | 2006-12-15 | Zoser B Salama | PHARMACEUTICAL COMPOSITION COMPRISING OXOPLATIN AND SALTS THEREOF |
-
2003
- 2003-10-13 AT AT03090344T patent/ATE346076T1/en not_active IP Right Cessation
- 2003-10-13 EP EP03090344A patent/EP1524273B1/en not_active Expired - Lifetime
- 2003-10-13 DE DE50305768T patent/DE50305768D1/en not_active Expired - Fee Related
-
2004
- 2004-10-13 CA CA2565096A patent/CA2565096C/en not_active Expired - Fee Related
- 2004-10-13 EP EP04789998A patent/EP1678189B1/en not_active Not-in-force
- 2004-10-13 WO PCT/DE2004/002296 patent/WO2005040045A2/en active IP Right Grant
- 2004-10-13 DK DK04789998T patent/DK1678189T3/en active
- 2004-10-13 RU RU2006116314/04A patent/RU2345086C2/en not_active IP Right Cessation
- 2004-10-13 JP JP2006534580A patent/JP4887153B2/en not_active Expired - Fee Related
- 2004-10-13 MX MXPA06003843A patent/MXPA06003843A/en active IP Right Grant
- 2004-10-13 BR BRPI0415295-6A patent/BRPI0415295A/en not_active IP Right Cessation
- 2004-10-13 US US10/595,400 patent/US7687651B2/en not_active Expired - Fee Related
- 2004-10-13 AU AU2004283125A patent/AU2004283125B2/en not_active Ceased
- 2004-10-13 DE DE502004003311T patent/DE502004003311D1/en active Active
- 2004-10-13 DE DE112004002485T patent/DE112004002485D2/en not_active Expired - Fee Related
- 2004-10-13 UA UAA200605216A patent/UA85066C2/en unknown
- 2004-10-13 ZA ZA200603018A patent/ZA200603018B/en unknown
- 2004-10-13 PL PL04789998T patent/PL1678189T3/en unknown
- 2004-10-13 ES ES04789998T patent/ES2284061T3/en active Active
- 2004-10-13 CN CNB2004800298890A patent/CN100526324C/en not_active Expired - Fee Related
- 2004-10-13 AT AT04789998T patent/ATE357451T1/en active
-
2007
- 2007-02-15 HK HK07101868.0A patent/HK1097848A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005040045A3 (en) | 2005-07-07 |
| EP1678189A2 (en) | 2006-07-12 |
| EP1524273B1 (en) | 2006-11-22 |
| CN1867573A (en) | 2006-11-22 |
| ATE346076T1 (en) | 2006-12-15 |
| EP1524273A1 (en) | 2005-04-20 |
| ZA200603018B (en) | 2007-07-25 |
| MXPA06003843A (en) | 2007-02-02 |
| RU2345086C2 (en) | 2009-01-27 |
| JP2007513066A (en) | 2007-05-24 |
| HK1097848A1 (en) | 2007-07-06 |
| CA2565096C (en) | 2011-02-22 |
| ES2284061T3 (en) | 2007-11-01 |
| DE502004003311D1 (en) | 2007-05-03 |
| US20070286905A1 (en) | 2007-12-13 |
| CN100526324C (en) | 2009-08-12 |
| EP1678189B1 (en) | 2007-03-21 |
| RU2006116314A (en) | 2007-11-20 |
| DE112004002485D2 (en) | 2006-08-24 |
| AU2004283125B2 (en) | 2009-06-25 |
| US7687651B2 (en) | 2010-03-30 |
| UA85066C2 (en) | 2008-12-25 |
| PL1678189T3 (en) | 2007-08-31 |
| JP4887153B2 (en) | 2012-02-29 |
| DK1678189T3 (en) | 2007-06-11 |
| WO2005040045A2 (en) | 2005-05-06 |
| DE50305768D1 (en) | 2007-01-04 |
| BRPI0415295A (en) | 2006-12-26 |
| AU2004283125A1 (en) | 2005-05-06 |
| CA2565096A1 (en) | 2005-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1097848A1 (en) | Method for the production of trans- or cis- diammoniumdichlorodihydroxoplatinum (iv) and use thereof for the production of pharmaceutical agent | |
| YU70901A (en) | 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof | |
| NO20050134L (en) | Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use | |
| ATE54154T1 (en) | RETRO-INVERSE ANALOGS OF BRADYKIN POTENTIALIZING PEPTIDE BPP-5A AND METHODS FOR THEIR PRODUCTION. | |
| IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| CY1111327T1 (en) | Substituted cyclohexylacetic acid derivatives | |
| MA27232A1 (en) | N-BENZOYLUREIDOCINNAMIC ACID DERIVATIVES, PREPARATION METHODS AND USES THEREOF | |
| DE502005003310D1 (en) | CYCLOALKYL SUBSTITUTED 7-AMINO-4-CHINOLONE-3-CARBOXYLIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICAMENT | |
| CN101326191B (en) | Phosphine transition metal complex, method for producing same and antitumor agent containing same | |
| HRP20050779A2 (en) | Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof | |
| SU741797A3 (en) | Method of preparing benzopyrane derivatives or their salts | |
| CA3144062A1 (en) | Compounds, compositions, and methods for protein degradation | |
| ATE491686T1 (en) | AMLODIPINE GENTISAT AND METHOD FOR THE PRODUCTION THEREOF | |
| TW200612943A (en) | 4-trifluoromethoxyphenoxybenzene-4'-sulfonic acids, process for their preparation and use in medicaments | |
| ES2222822A1 (en) | Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents | |
| CN114957064B (en) | Compound for inhibiting MCU5AC secretion and pharmaceutical application thereof | |
| Mear | Stereoselective and Economical Methods for Chemical Synthesis of Essential Medicines | |
| CN118146289A (en) | Positive and negative regulation NAMPT and NAD+Optically controlled PROTAC compounds and uses thereof | |
| HUP0001727A2 (en) | Novel 1-aza-2-alkyl-6-aryl-cycloalkane compounds, process for producing them and medicaments containing the same | |
| JPS60258161A (en) | Preparation of cysteine derivative | |
| AR127964A1 (en) | NOVEL SALT OF A DERIVATIVE OF 1-SULFONYLPYRROL, METHOD OF PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THE SAME | |
| EP2340020A1 (en) | Manganese and cobalt complexes, their preparation and use | |
| TH76318A (en) | 4-trifluorometholsifoxibenzene -4'-sulfonic acid, a process for the production of these substances And use in medicinal substances | |
| CN105985380A (en) | Mitochondrial targeting superoxide anion imaging probe and preparation method thereof | |
| JP2007070278A (en) | Medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner |